25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Kyung Dong Pharmaceutical Co. Ltd
Buy, Hold or Sell?

Let's analyze Kyung Dong Pharmaceutical Co. Ltd together

I guess you are interested in Kyung Dong Pharmaceutical Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kyung Dong Pharmaceutical Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Kyung Dong Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Kyung Dong Pharmaceutical Co. Ltd.

1. Quick Overview

1.1. Quick analysis of Kyung Dong Pharmaceutical Co. Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Kyung Dong Pharmaceutical Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
82.5%

What is your share worth?

Current worth
₩8,107.53
Expected worth in 1 year
₩7,143.20
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
₩-964.33
Return On Investment
-15.9%

For what price can you sell your share?

Current Price per Share
₩6,080.00
Expected price per share
₩5,825 - ₩6,430
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Kyung Dong Pharmaceutical Co. Ltd (5 min.)




Live pricePrice per Share (EOD)
₩6,080.00

2.2. Growth of Kyung Dong Pharmaceutical Co. Ltd (5 min.)




Is Kyung Dong Pharmaceutical Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$152.9m$174.8m-$15.9m-10.0%

How much money is Kyung Dong Pharmaceutical Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$2.8m$1.4m-$4.3m-150.6%
Net Profit Margin-9.3%4.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Kyung Dong Pharmaceutical Co. Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Kyung Dong Pharmaceutical Co. Ltd?

Welcome investor! Kyung Dong Pharmaceutical Co. Ltd's management wants to use your money to grow the business. In return you get a share of Kyung Dong Pharmaceutical Co. Ltd.

First you should know what it really means to hold a share of Kyung Dong Pharmaceutical Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Kyung Dong Pharmaceutical Co. Ltd is ₩6,080. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kyung Dong Pharmaceutical Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kyung Dong Pharmaceutical Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩8,107.53. Based on the TTM, the Book Value Change Per Share is ₩-241.08 per quarter. Based on the YOY, the Book Value Change Per Share is ₩15.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kyung Dong Pharmaceutical Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%-0.110.0%0.050.0%0.050.0%0.080.0%
Usd Book Value Change Per Share0.080.0%-0.170.0%0.010.0%-0.050.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.210.0%0.190.0%0.190.0%
Usd Total Gains Per Share0.080.0%-0.170.0%0.220.0%0.140.0%0.200.0%
Usd Price Per Share4.68-4.63-5.12-6.15-9.70-
Price to Earnings Ratio30.71-36.50--27.40-12.00-32.67-
Price-to-Total Gains Ratio60.33--45.23-5.97-53.09-45.13-
Price to Book Ratio0.83-0.79-0.79-0.93-1.55-
Price-to-Total Gains Ratio60.33--45.23-5.97-53.09-45.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.256
Number of shares234
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.19
Usd Book Value Change Per Share-0.17-0.05
Usd Total Gains Per Share-0.170.14
Gains per Quarter (234 shares)-39.4933.10
Gains per Year (234 shares)-157.96132.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-158-168175-43122
20-316-326350-85254
30-474-484525-128386
40-632-642700-170518
50-790-800875-213650
60-948-9581050-255782
70-1106-11161225-298914
80-1264-12741400-3401046
90-1422-14321575-3831178
100-1580-15901750-4261310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%16.04.00.080.0%35.05.00.087.5%41.05.00.089.1%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%23.017.00.057.5%29.017.00.063.0%
Dividend per Share0.00.04.00.0%7.00.05.058.3%15.00.05.075.0%33.00.07.082.5%37.00.09.080.4%
Total Gains per Share1.03.00.025.0%8.04.00.066.7%14.06.00.070.0%32.08.00.080.0%38.08.00.082.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Kyung Dong Pharmaceutical Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--110.898-241.083+317%15.192+630%-64.950+159%16.116+588%
Book Value Per Share--8107.5328391.337-3%9201.408-12%9367.601-13%9099.778-11%
Current Ratio--1.2651.647-23%2.237-43%3.485-64%2.579-51%
Debt To Asset Ratio--0.2830.229+24%0.161+75%0.166+71%0.152+86%
Debt To Equity Ratio--0.3950.303+30%0.193+105%0.204+94%0.183+116%
Dividend Per Share----0%300.515-100%267.056-100%273.966-100%
Eps--54.465-152.188+379%76.978-29%65.010-16%114.691-53%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap142991264000.000-26%180240441300.000179091125702.500+1%198392749275.000-9%227404076155.500-21%336677265002.750-46%
Net Profit Margin--0.030-0.093+414%0.042-30%0.036-18%0.066-55%
Operating Margin----0%0.020-100%0.053-100%0.058-100%
Operating Ratio--0.8001.374-42%0.965-17%0.818-2%0.793+1%
Pb Ratio0.750-10%0.8250.790+4%0.794+4%0.932-12%1.553-47%
Pe Ratio27.908-10%30.70836.503-16%-27.405+189%12.001+156%32.674-6%
Price Per Share6080.000-10%6690.0006620.000+1%7307.500-8%8787.500-24%13863.500-52%
Price To Free Cash Flow Ratio----36.1510%-598.3990%-127.6460%-55.6640%
Price To Total Gains Ratio54.825-10%60.326-45.234+175%5.965+911%53.092+14%45.126+34%
Quick Ratio---0.576-100%2.088-100%3.092-100%2.057-100%
Return On Assets--0.005-0.014+394%0.007-29%0.006-23%0.011-57%
Return On Equity--0.007-0.018+368%0.008-17%0.007-8%0.013-49%
Total Gains Per Share--110.898-241.083+317%315.707-65%202.105-45%290.083-62%
Usd Book Value--152901878.500158925637.217-4%174865854.791-13%169655285.926-10%157667256.906-3%
Usd Book Value Change Per Share--0.078-0.169+317%0.011+630%-0.045+159%0.011+588%
Usd Book Value Per Share--5.6755.874-3%6.441-12%6.557-13%6.370-11%
Usd Dividend Per Share----0%0.210-100%0.187-100%0.192-100%
Usd Eps--0.038-0.107+379%0.054-29%0.046-16%0.080-53%
Usd Free Cash Flow----3791528.2740%-3233240.0520%-1643983.1580%1146700.913-100%
Usd Market Cap100093884.800-26%126168308.910125363787.992+1%138874924.493-9%159182853.309-21%235674085.502-46%
Usd Price Per Share4.256-10%4.6834.634+1%5.115-8%6.151-24%9.704-52%
Usd Profit--1027161.100-2893533.678+382%1464052.984-30%1268016.980-19%1988107.276-48%
Usd Revenue--34783039.90031253934.716+11%30474992.861+14%32338065.842+8%30700629.135+13%
Usd Total Gains Per Share--0.078-0.169+317%0.221-65%0.141-45%0.203-62%
 EOD+3 -4MRQTTM+17 -9YOY+6 -235Y+7 -2210Y+7 -23

3.3 Fundamental Score

Let's check the fundamental score of Kyung Dong Pharmaceutical Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.908
Price to Book Ratio (EOD)Between0-10.750
Net Profit Margin (MRQ)Greater than00.030
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.265
Debt to Asset Ratio (MRQ)Less than10.283
Debt to Equity Ratio (MRQ)Less than10.395
Return on Equity (MRQ)Greater than0.150.007
Return on Assets (MRQ)Greater than0.050.005
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Kyung Dong Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.040
Ma 20Greater thanMa 506,188.000
Ma 50Greater thanMa 1006,244.000
Ma 100Greater thanMa 2006,480.100
OpenGreater thanClose6,140.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Kyung Dong Pharmaceutical Co. Ltd

Kyung Dong Pharmaceutical Co., Ltd. produces and sells specialized and general medicines in South Korea. It offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, antihistamine, CNS, antiobesity, neuropathic, osteoporosis, respiratory, allergy, and arthrifuge categories. The company also provides OTC medicines for pain/inflammation, cardiovascular, hepatic protectors, respiratory, gastrointestinal, calcium agent, antihistamine, antifungal, antibiotic, anti-inflammatory enzyme, dermatologic, antiviral, and contraceptive categories; and APIs and health functional foods, as well as quasi drugs. The company was formerly known as Yuil Trading Company and changed its name to Kyung Dong Pharmaceutical Co., Ltd. in February 1976. Kyung Dong Pharmaceutical Co., Ltd. was founded in 1975 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 06:49:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Kyung Dong Pharmaceutical Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 3.0% means that ₩0.03 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 3.0%. The company is making a profit. +1
  • The TTM is -9.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ3.0%TTM-9.3%+12.2%
TTM-9.3%YOY4.2%-13.5%
TTM-9.3%5Y3.6%-12.9%
5Y3.6%10Y6.6%-3.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0%9.8%-6.8%
TTM-9.3%9.5%-18.8%
YOY4.2%10.4%-6.2%
5Y3.6%12.9%-9.3%
10Y6.6%12.6%-6.0%
4.3.1.2. Return on Assets

Shows how efficient Kyung Dong Pharmaceutical Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • 0.5% Return on Assets means that Kyung Dong Pharmaceutical Co. Ltd generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.5%TTM-1.4%+1.9%
TTM-1.4%YOY0.7%-2.1%
TTM-1.4%5Y0.6%-2.0%
5Y0.6%10Y1.1%-0.5%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%3.6%-3.1%
TTM-1.4%3.6%-5.0%
YOY0.7%5.3%-4.6%
5Y0.6%5.9%-5.3%
10Y1.1%4.9%-3.8%
4.3.1.3. Return on Equity

Shows how efficient Kyung Dong Pharmaceutical Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • 0.7% Return on Equity means Kyung Dong Pharmaceutical Co. Ltd generated ₩0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.7%TTM-1.8%+2.5%
TTM-1.8%YOY0.8%-2.6%
TTM-1.8%5Y0.7%-2.5%
5Y0.7%10Y1.3%-0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%4.6%-3.9%
TTM-1.8%4.6%-6.4%
YOY0.8%8.2%-7.4%
5Y0.7%9.1%-8.4%
10Y1.3%10.3%-9.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Kyung Dong Pharmaceutical Co. Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Kyung Dong Pharmaceutical Co. Ltd is operating .

  • Measures how much profit Kyung Dong Pharmaceutical Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY2.0%-2.0%
TTM-5Y5.3%-5.3%
5Y5.3%10Y5.8%-0.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.5%-12.5%
TTM-12.0%-12.0%
YOY2.0%12.5%-10.5%
5Y5.3%8.6%-3.3%
10Y5.8%12.1%-6.3%
4.3.2.2. Operating Ratio

Measures how efficient Kyung Dong Pharmaceutical Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 0.80 means that the operating costs are ₩0.80 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.800. The company is efficient in keeping operating costs low. +1
  • The TTM is 1.374. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.800TTM1.374-0.574
TTM1.374YOY0.965+0.409
TTM1.3745Y0.818+0.556
5Y0.81810Y0.793+0.025
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8001.225-0.425
TTM1.3741.220+0.154
YOY0.9651.311-0.346
5Y0.8181.249-0.431
10Y0.7931.240-0.447
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Kyung Dong Pharmaceutical Co. Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Kyung Dong Pharmaceutical Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.26 means the company has ₩1.26 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 1.265. The company is just able to pay all its short-term debts.
  • The TTM is 1.647. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.265TTM1.647-0.382
TTM1.647YOY2.237-0.591
TTM1.6475Y3.485-1.838
5Y3.48510Y2.579+0.906
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2652.213-0.948
TTM1.6472.234-0.587
YOY2.2372.023+0.214
5Y3.4852.199+1.286
10Y2.5791.995+0.584
4.4.3.2. Quick Ratio

Measures if Kyung Dong Pharmaceutical Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.576-0.576
TTM0.576YOY2.088-1.512
TTM0.5765Y3.092-2.516
5Y3.09210Y2.057+1.036
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM0.5760.973-0.397
YOY2.0881.515+0.573
5Y3.0921.580+1.512
10Y2.0571.386+0.671
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Kyung Dong Pharmaceutical Co. Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Kyung Dong Pharmaceutical Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.28 means that Kyung Dong Pharmaceutical Co. Ltd assets are financed with 28.3% credit (debt) and the remaining percentage (100% - 28.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.283. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.229. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.283TTM0.229+0.054
TTM0.229YOY0.161+0.067
TTM0.2295Y0.166+0.063
5Y0.16610Y0.152+0.014
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2830.345-0.062
TTM0.2290.339-0.110
YOY0.1610.333-0.172
5Y0.1660.315-0.149
10Y0.1520.339-0.187
4.5.4.2. Debt to Equity Ratio

Measures if Kyung Dong Pharmaceutical Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 39.5% means that company has ₩0.40 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.395. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.303. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.303+0.092
TTM0.303YOY0.193+0.110
TTM0.3035Y0.204+0.099
5Y0.20410Y0.183+0.021
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3950.547-0.152
TTM0.3030.547-0.244
YOY0.1930.499-0.306
5Y0.2040.476-0.272
10Y0.1830.548-0.365
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Kyung Dong Pharmaceutical Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Kyung Dong Pharmaceutical Co. Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 30.71 means the investor is paying ₩30.71 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The EOD is 27.908. Based on the earnings, the company is overpriced. -1
  • The MRQ is 30.708. Based on the earnings, the company is overpriced. -1
  • The TTM is 36.503. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD27.908MRQ30.708-2.800
MRQ30.708TTM36.503-5.795
TTM36.503YOY-27.405+63.907
TTM36.5035Y12.001+24.502
5Y12.00110Y32.674-20.674
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD27.90828.551-0.643
MRQ30.70829.844+0.864
TTM36.50328.516+7.987
YOY-27.40522.679-50.084
5Y12.00127.619-15.618
10Y32.67429.248+3.426
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-36.151+36.151
TTM-36.151YOY-598.399+562.248
TTM-36.1515Y-127.646+91.495
5Y-127.64610Y-55.664-71.982
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.462-29.462
TTM-36.15129.447-65.598
YOY-598.39920.307-618.706
5Y-127.64631.734-159.380
10Y-55.66434.357-90.021
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Kyung Dong Pharmaceutical Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 0.83 means the investor is paying ₩0.83 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Kyung Dong Pharmaceutical Co. Ltd:

  • The EOD is 0.750. Based on the equity, the company is cheap. +2
  • The MRQ is 0.825. Based on the equity, the company is cheap. +2
  • The TTM is 0.790. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.750MRQ0.825-0.075
MRQ0.825TTM0.790+0.035
TTM0.790YOY0.794-0.003
TTM0.7905Y0.932-0.142
5Y0.93210Y1.553-0.620
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD0.7504.671-3.921
MRQ0.8253.381-2.556
TTM0.7903.209-2.419
YOY0.7942.597-1.803
5Y0.9323.278-2.346
10Y1.5534.253-2.700
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -3,585,3692,004,874-1,580,495-14,095,219-15,675,71414,907,889-767,82530,586,74329,818,918



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets304,637,267
Total Liabilities86,206,012
Total Stockholder Equity218,144,244
 As reported
Total Liabilities 86,206,012
Total Stockholder Equity+ 218,144,244
Total Assets = 304,637,267

Assets

Total Assets304,637,267
Total Current Assets104,000,787
Long-term Assets200,636,481
Total Current Assets
Total Current Assets  (as reported)104,000,787
Total Current Assets  (calculated)0
+/- 104,000,787
Long-term Assets
Long-term Assets  (as reported)200,636,481
Long-term Assets  (calculated)0
+/- 200,636,481

Liabilities & Shareholders' Equity

Total Current Liabilities82,237,111
Long-term Liabilities3,968,901
Total Stockholder Equity218,144,244
Total Current Liabilities
Total Current Liabilities  (as reported)82,237,111
Total Current Liabilities  (calculated)0
+/- 82,237,111
Long-term Liabilities
Long-term Liabilities  (as reported)3,968,901
Long-term Liabilities  (calculated)0
+/- 3,968,901
Total Stockholder Equity
Total Stockholder Equity (as reported)218,144,244
Total Stockholder Equity (calculated)0
+/- 218,144,244
Other
Common Stock Shares Outstanding 26,942
Net Invested Capital 218,144,244
Net Working Capital 21,763,676



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
194,831,836
186,872,590
196,647,018
200,386,087
207,203,461
206,956,048
213,595,428
227,679,294
224,843,857
234,183,817
232,397,250
233,410,410
239,425,125
235,435,565
234,517,319
238,488,083
242,375,657
241,273,805
250,879,454
251,427,545
255,717,317
245,097,809
252,221,247
257,792,241
262,514,641
258,837,684
286,060,731
287,589,289
280,868,750
276,216,587
288,235,744
291,393,608
294,746,363
294,010,811
288,460,283
291,974,102
288,468,652
273,248,377
289,428,829
310,477,908
300,215,530
291,890,313
287,100,605
292,970,765
294,348,572
304,637,267
304,637,267294,348,572292,970,765287,100,605291,890,313300,215,530310,477,908289,428,829273,248,377288,468,652291,974,102288,460,283294,010,811294,746,363291,393,608288,235,744276,216,587280,868,750287,589,289286,060,731258,837,684262,514,641257,792,241252,221,247245,097,809255,717,317251,427,545250,879,454241,273,805242,375,657238,488,083234,517,319235,435,565239,425,125233,410,410232,397,250234,183,817224,843,857227,679,294213,595,428206,956,048207,203,461200,386,087196,647,018186,872,590194,831,836
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,124,963
110,078,593
110,127,126
115,833,735
122,431,119
129,530,050
126,151,982
126,325,745
111,733,743
139,145,913
142,312,197
143,388,305
130,630,656
142,437,588
109,754,590
112,006,728
104,303,235
105,001,049
103,208,391
104,344,150
88,818,820
104,282,051
102,981,142
99,399,196
94,795,371
99,208,571
89,748,781
93,607,527
104,000,787
104,000,78793,607,52789,748,78199,208,57194,795,37199,399,196102,981,142104,282,05188,818,820104,344,150103,208,391105,001,049104,303,235112,006,728109,754,590142,437,588130,630,656143,388,305142,312,197139,145,913111,733,743126,325,745126,151,982129,530,050122,431,119115,833,735110,127,126110,078,593106,124,96300000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,712,470
24,450,463
25,130,235
38,834,757
24,952,927
37,789,163
30,129,804
34,639,090
40,901,162
58,027,028
62,939,274
57,518,677
27,839,354
46,534,374
15,978,966
31,494,995
28,547,550
15,952,966
560
1,774
1,955
3,060
2,973
2,825
621,739
13,374,334
11,779,415
13,149,677
0
013,149,67711,779,41513,374,334621,7392,8252,9733,0601,9551,77456015,952,96628,547,55031,494,99515,978,96646,534,37427,839,35457,518,67762,939,27458,027,02840,901,16234,639,09030,129,80437,789,16324,952,92738,834,75725,130,23524,450,46318,712,47000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,745,079
32,745,079
33,745,079
30,644,579
53,492,729
45,114,129
0
45,328,978
16,135,078
14,120,000
13,150,000
0
0
47,971,543
45,356,130
34,275,417
27,287,505
32,948,027
32,235,908
35,423,141
21,469,531
30,497,736
30,574,888
30,313,481
30,098,992
29,619,345
20,295,112
18,659,028
0
018,659,02820,295,11229,619,34530,098,99230,313,48130,574,88830,497,73621,469,53135,423,14132,235,90832,948,02727,287,50534,275,41745,356,13047,971,5430013,150,00014,120,00016,135,07845,328,978045,114,12953,492,72930,644,57933,745,07932,745,07939,745,07900000000000000000
       Net Receivables 
12,746,186
9,980,153
14,497,062
11,701,814
11,168,062
12,725,741
16,723,451
18,173,757
14,764,611
15,457,116
17,101,817
13,156,485
10,576,310
11,019,048
15,602,842
14,249,901
12,627,418
12,744,425
19,473,591
21,644,390
15,874,754
14,227,720
17,910,717
14,989,231
13,378,052
12,677,610
15,429,288
20,240,593
13,524,859
12,200,019
15,822,449
18,642,739
14,535,417
14,171,553
21,855,619
21,507,976
20,683,081
15,195,825
21,732,278
25,373,707
19,605,774
17,470,428
16,119,609
19,156,136
15,944,496
0
015,944,49619,156,13616,119,60917,470,42819,605,77425,373,70721,732,27815,195,82520,683,08121,507,97621,855,61914,171,55314,535,41718,642,73915,822,44912,200,01913,524,85920,240,59315,429,28812,677,61013,378,05214,989,23117,910,71714,227,72015,874,75421,644,39019,473,59112,744,42512,627,41814,249,90115,602,84211,019,04810,576,31013,156,48517,101,81715,457,11614,764,61118,173,75716,723,45112,725,74111,168,06211,701,81414,497,0629,980,15312,746,186
       Other Current Assets 
1,508,702
1,724,308
2,500,298
2,191,044
1,418,293
1,619,730
1,962,244
1,974,171
1,894,706
1,878,461
1,717,592
1,810,608
1,545,669
1,988,225
1,684,966
2,104,014
4,712,751
6,070,544
5,897,156
1,412,576
3,914,843
2,651,242
1,143,298
734,572
807,410
442,622
1,981,607
1,841,754
2,136,507
1,963,671
1,322,089
776,294
737,608
2,023,510
864,572
1,021,881
1,464,224
7,026,629
5,210,639
1,245,825
983,911
936,438
-1
-1
0
0
00-1-1936,438983,9111,245,8255,210,6397,026,6291,464,2241,021,881864,5722,023,510737,608776,2941,322,0891,963,6712,136,5071,841,7541,981,607442,622807,410734,5721,143,2982,651,2423,914,8431,412,5765,897,1566,070,5444,712,7512,104,0141,684,9661,988,2251,545,6691,810,6081,717,5921,878,4611,894,7061,974,1711,962,2441,619,7301,418,2932,191,0442,500,2981,724,3081,508,702
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
207,496,767
200,816,334
197,094,942
187,892,035
203,221,985
200,741,045
200,636,481
200,636,481200,741,045203,221,985187,892,035197,094,942200,816,334207,496,767000000000000000000000000000000000000000
       Property Plant Equipment 
42,566,873
46,942,480
49,528,627
49,989,346
55,640,596
59,171,977
64,123,907
68,411,445
69,696,688
71,491,632
71,357,226
73,800,657
73,825,978
73,311,661
75,285,832
71,250,054
71,493,641
71,101,926
70,247,077
70,828,547
69,886,575
68,444,627
68,214,666
67,969,699
69,826,900
68,576,582
67,525,388
66,513,021
65,861,584
68,956,432
67,960,797
88,585,500
87,705,568
90,274,072
89,470,963
89,879,631
88,000,979
86,753,113
85,826,852
95,097,242
91,871,045
85,050,813
73,383,277
73,646,410
74,077,492
0
074,077,49273,646,41073,383,27785,050,81391,871,04595,097,24285,826,85286,753,11388,000,97989,879,63189,470,96390,274,07287,705,56888,585,50067,960,79768,956,43265,861,58466,513,02167,525,38868,576,58269,826,90067,969,69968,214,66668,444,62769,886,57570,828,54770,247,07771,101,92671,493,64171,250,05475,285,83273,311,66173,825,97873,800,65771,357,22671,491,63269,696,68868,411,44564,123,90759,171,97755,640,59649,989,34649,528,62746,942,48042,566,873
       Goodwill 
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
500,000
450,000
450,000
450,000
450,000
450,000
450,000
450,000
450,000
450,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000450,000450,000450,000450,000450,000450,000450,000450,000450,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000500,000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,900,952
39,733,430
40,182,058
40,134,606
24,061,594
23,939,983
33,502,440
35,629,173
43,188,873
49,457,485
50,326,187
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000050,326,18749,457,48543,188,87335,629,17333,502,44023,939,98324,061,59440,134,60640,182,05839,733,43033,900,95200000000000000000
       Intangible Assets 
3,245,634
3,186,247
3,179,905
3,173,610
3,667,315
3,728,878
3,722,597
3,716,178
3,709,944
3,935,512
4,094,791
4,100,106
4,094,023
4,088,009
4,082,022
4,075,790
4,069,928
4,014,077
4,008,266
4,002,485
3,792,317
3,336,644
3,430,986
3,161,690
3,156,113
3,127,535
2,466,845
2,459,935
2,452,021
2,445,213
2,192,461
2,193,805
2,211,260
2,208,032
2,217,417
2,998,093
1,771,196
1,770,363
2,290,151
2,888,992
3,884,116
3,955,627
4,082,377
5,688,886
5,652,006
0
05,652,0065,688,8864,082,3773,955,6273,884,1162,888,9922,290,1511,770,3631,771,1962,998,0932,217,4172,208,0322,211,2602,193,8052,192,4612,445,2132,452,0212,459,9352,466,8453,127,5353,156,1133,161,6903,430,9863,336,6443,792,3174,002,4854,008,2664,014,0774,069,9284,075,7904,082,0224,088,0094,094,0234,100,1064,094,7913,935,5123,709,9443,716,1783,722,5973,728,8783,667,3153,173,6103,179,9053,186,2473,245,634
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
95,001
94,999
94,999
95,000
95,000
0
095,00095,00094,99994,99995,001-1000000000000000000000000000000000000000
> Total Liabilities 
44,177,339
31,505,897
32,226,249
31,354,799
36,675,876
31,441,789
29,581,502
37,248,824
34,657,274
35,221,538
29,983,247
28,970,831
37,400,766
29,508,406
28,326,101
29,916,613
36,864,276
30,688,148
31,727,008
32,079,385
41,492,363
27,594,512
28,624,596
40,011,986
43,845,735
36,106,782
58,094,305
60,883,275
65,188,145
54,189,128
36,558,372
29,206,769
37,305,501
31,781,139
29,670,248
32,153,103
38,487,135
27,842,248
41,459,058
53,273,977
52,309,645
45,736,445
41,789,892
64,493,723
78,421,084
86,206,012
86,206,01278,421,08464,493,72341,789,89245,736,44552,309,64553,273,97741,459,05827,842,24838,487,13532,153,10329,670,24831,781,13937,305,50129,206,76936,558,37254,189,12865,188,14560,883,27558,094,30536,106,78243,845,73540,011,98628,624,59627,594,51241,492,36332,079,38531,727,00830,688,14836,864,27629,916,61328,326,10129,508,40637,400,76628,970,83129,983,24735,221,53834,657,27437,248,82429,581,50231,441,78936,675,87631,354,79932,226,24931,505,89744,177,339
   > Total Current Liabilities 
38,385,633
26,258,867
26,687,148
26,609,027
31,655,439
26,668,210
24,560,384
32,003,903
28,648,100
27,936,693
22,615,276
20,500,653
30,609,650
25,107,088
24,459,895
27,194,063
35,130,364
27,447,736
29,837,962
29,908,482
39,315,718
25,422,455
26,771,199
39,415,220
40,788,853
33,482,779
23,965,249
23,148,224
36,040,009
25,382,653
25,362,677
25,998,644
33,905,453
24,302,571
22,689,200
25,363,945
32,689,141
23,611,580
38,098,609
50,126,818
50,643,398
43,188,653
39,399,828
59,027,091
72,900,914
82,237,111
82,237,11172,900,91459,027,09139,399,82843,188,65350,643,39850,126,81838,098,60923,611,58032,689,14125,363,94522,689,20024,302,57133,905,45325,998,64425,362,67725,382,65336,040,00923,148,22423,965,24933,482,77940,788,85339,415,22026,771,19925,422,45539,315,71829,908,48229,837,96227,447,73635,130,36427,194,06324,459,89525,107,08830,609,65020,500,65322,615,27627,936,69328,648,10032,003,90324,560,38426,668,21031,655,43926,609,02726,687,14826,258,86738,385,633
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,097,047
4,275,509
4,402,447
1,029,997
967,423
0
0
0
0
82,636
18,071
44,028
103,107
238,145
635,874
305,000
123,441
79,823
153,948
35,721
102,995
12,799,892
24,084,910
12,173,255
18,391,750
0
0
0
0
000018,391,75012,173,25524,084,91012,799,892102,99535,721153,94879,823123,441305,000635,874238,145103,10744,02818,07182,6360000967,4231,029,9974,402,4474,275,5093,097,04700000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,097,047
4,275,509
4,402,447
1,029,997
967,423
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,084,910
12,173,255
18,391,750
15,795,603
15,015,475
33,075,719
0
033,075,71915,015,47515,795,60318,391,75012,173,25524,084,91000000000000000000967,4231,029,9974,402,4474,275,5093,097,04700000000000000000
       Accounts payable 
6,352,953
8,658,955
9,422,551
7,806,720
6,346,057
6,982,647
5,582,264
11,033,525
6,473,738
6,235,449
5,609,534
4,466,035
4,734,364
5,770,903
6,273,757
7,496,341
6,133,399
7,021,377
8,471,034
10,319,442
7,770,052
7,172,072
7,727,874
5,663,042
7,588,774
9,467,186
5,423,255
6,141,467
8,012,232
7,277,046
6,523,941
3,878,173
3,661,741
4,265,484
4,645,915
5,750,749
3,609,348
5,201,862
9,042,808
5,657,357
4,531,082
4,549,646
4,479,742
4,880,456
6,853,924
0
06,853,9244,880,4564,479,7424,549,6464,531,0825,657,3579,042,8085,201,8623,609,3485,750,7494,645,9154,265,4843,661,7413,878,1736,523,9417,277,0468,012,2326,141,4675,423,2559,467,1867,588,7745,663,0427,727,8747,172,0727,770,05210,319,4428,471,0347,021,3776,133,3997,496,3416,273,7575,770,9034,734,3644,466,0355,609,5346,235,4496,473,73811,033,5255,582,2646,982,6476,346,0577,806,7209,422,5518,658,9556,352,953
       Other Current Liabilities 
28,616,272
14,145,012
13,347,487
15,228,587
21,923,390
16,353,449
15,708,846
17,670,833
18,773,047
18,444,401
13,712,978
12,637,480
22,665,488
16,014,490
15,169,249
16,357,943
25,909,760
17,329,312
17,091,419
15,186,593
30,515,669
15,986,561
16,958,266
31,565,721
29,550,788
20,968,654
15,600,368
14,256,756
25,112,356
15,178,974
16,398,687
19,309,564
27,856,912
16,887,644
14,941,958
16,474,634
26,012,604
15,222,294
13,385,992
1,648,660
549,791
455,434
576,594
710,356
553,161
0
0553,161710,356576,594455,434549,7911,648,66013,385,99215,222,29426,012,60416,474,63414,941,95816,887,64427,856,91219,309,56416,398,68715,178,97425,112,35614,256,75615,600,36820,968,65429,550,78831,565,72116,958,26615,986,56130,515,66915,186,59317,091,41917,329,31225,909,76016,357,94315,169,24916,014,49022,665,48812,637,48013,712,97818,444,40118,773,04717,670,83315,708,84616,353,44921,923,39015,228,58713,347,48714,145,01228,616,272
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,826,327
1,346,107
2,237,396
2,390,064
5,466,632
5,520,170
3,968,901
3,968,9015,520,1705,466,6322,390,0642,237,3961,346,1072,826,327000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,575,288
25,916,161
25,987,972
26,221,412
8,137,831
420,564
355,795
2,921,675
2,785,248
2,686,161
2,337,154
2,019,517
1,726,619
1,434,128
368,106
271,084
0
0
0
0
0000271,084368,1061,434,1281,726,6192,019,5172,337,1542,686,1612,785,2482,921,675355,795420,5648,137,83126,221,41225,987,97225,916,16120,575,28800000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,097,047
-4,275,509
-4,402,447
-1,029,997
-967,423
0
0
0
0
-82,636
-18,071
-44,028
-103,107
-238,145
-635,874
-305,000
-123,441
-79,823
-153,948
-35,721
-102,995
-12,799,892
-21,300,406
-11,323,762
-17,731,520
508,154
357,717
173,945
0
0173,945357,717508,154-17,731,520-11,323,762-21,300,406-12,799,892-102,995-35,721-153,948-79,823-123,441-305,000-635,874-238,145-103,107-44,028-18,071-82,6360000-967,423-1,029,997-4,402,447-4,275,509-3,097,04700000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147,254
149,908
151,124
151,916
2,059,797
2,249,089
0
02,249,0892,059,797151,916151,124149,908147,254000000000000000000000000000000000000000
> Total Stockholder Equity
150,711,980
155,529,876
164,748,569
169,448,275
171,010,834
176,208,917
183,909,840
190,271,045
190,138,416
198,829,683
203,064,679
205,135,202
202,706,158
206,646,923
206,993,233
209,926,808
206,918,158
212,246,411
220,821,742
220,954,659
214,096,819
217,348,564
223,430,826
211,716,269
212,529,518
217,000,221
227,966,426
226,706,013
215,680,605
222,027,460
251,677,372
262,186,839
257,440,862
262,229,671
258,790,036
259,820,999
249,981,517
245,406,129
247,969,771
257,203,932
247,905,885
246,153,868
244,999,416
228,178,979
215,637,809
218,144,244
218,144,244215,637,809228,178,979244,999,416246,153,868247,905,885257,203,932247,969,771245,406,129249,981,517259,820,999258,790,036262,229,671257,440,862262,186,839251,677,372222,027,460215,680,605226,706,013227,966,426217,000,221212,529,518211,716,269223,430,826217,348,564214,096,819220,954,659220,821,742212,246,411206,918,158209,926,808206,993,233206,646,923202,706,158205,135,202203,064,679198,829,683190,138,416190,271,045183,909,840176,208,917171,010,834169,448,275164,748,569155,529,876150,711,980
   Common Stock
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
13,575,000
15,047,802
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
15,684,383
0
0
0
0
000015,684,38315,684,38315,684,38315,684,38315,684,38315,684,38315,684,38315,684,38315,684,38315,684,38315,684,38315,047,80213,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,00013,575,000
   Retained Earnings 
149,687,206
153,954,951
161,964,776
0
167,862,624
173,326,566
179,439,936
0
182,761,591
187,705,949
187,990,567
0
188,868,409
0
198,797,812
0
199,474,072
204,936,702
212,954,912
213,870,009
210,826,100
214,426,693
220,656,598
209,404,078
206,639,102
210,201,918
219,027,504
221,138,339
214,756,687
217,953,007
224,457,143
227,039,725
220,603,231
222,917,677
225,477,244
228,447,003
220,800,763
218,586,392
220,469,220
231,799,656
220,678,499
219,010,039
219,675,363
198,616,236
188,983,231
0
0188,983,231198,616,236219,675,363219,010,039220,678,499231,799,656220,469,220218,586,392220,800,763228,447,003225,477,244222,917,677220,603,231227,039,725224,457,143217,953,007214,756,687221,138,339219,027,504210,201,918206,639,102209,404,078220,656,598214,426,693210,826,100213,870,009212,954,912204,936,702199,474,0720198,797,8120188,868,4090187,990,567187,705,949182,761,5910179,439,936173,326,566167,862,6240161,964,776153,954,951149,687,206
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,753,189
3,415,465
10,226,454
3,415,464
20,172,449
27,387,176
27,348,351
27,348,351
27,348,351
27,348,351
27,348,351
27,348,351
27,237,857
27,237,857
27,237,857
27,237,857
0
0
0
0
000027,237,85727,237,85727,237,85727,237,85727,348,35127,348,35127,348,35127,348,35127,348,35127,348,35127,387,17620,172,4493,415,46410,226,4543,415,46512,753,18900000000000000000000000000
   Treasury Stock0000000000-28,165,781-26,500,328-25,321,889-22,648,515-22,889,975-22,889,975-22,889,9750-21,534,97200000-21,534,972-22,284,863-22,284,863-22,734,798-22,734,798-22,734,798-22,734,798-22,734,7980-19,961,696-19,961,696-19,961,696-21,423,157-21,423,157-21,423,157-21,423,157-21,423,157-21,423,157-21,423,157-21,423,157-21,587,156-21,587,156
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,162,366
8,719,487
7,318,840
5,219,089
3,730,265
-17,952,350
3,120,584
6,698,810
7,606,696
-17,389,267
3,299,976
-715,817
3,162,974
8,078,963
8,154,540
9,582,481
14,730,721
9,909,958
9,636,616
7,443,373
5,082,356
6,412,473
6,798,390
6,831,212
6,843,442
0
0
0
0
00006,843,4426,831,2126,798,3906,412,4735,082,3567,443,3739,636,6169,909,95814,730,7219,582,4818,154,5408,078,9633,162,974-715,8173,299,976-17,389,2677,606,6966,698,8103,120,584-17,952,3503,730,2655,219,0897,318,8408,719,4878,162,36600000000000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue162,674,099
Cost of Revenue-73,261,360
Gross Profit89,412,73989,412,739
 
Operating Income (+$)
Gross Profit89,412,739
Operating Expense-187,628,656
Operating Income-24,954,557-98,215,917
 
Operating Expense (+$)
Research Development13,827,408
Selling General Administrative72,095,859
Selling And Marketing Expenses0
Operating Expense187,628,65685,923,267
 
Net Interest Income (+$)
Interest Income2,447,700
Interest Expense-1,596,371
Other Finance Cost-0
Net Interest Income851,329
 
Pretax Income (+$)
Operating Income-24,954,557
Net Interest Income851,329
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-18,503,488-24,954,557
EBIT - interestExpense = -1,596,371
-20,707,555
-19,111,184
Interest Expense1,596,371
Earnings Before Interest and Taxes (EBIT)0-16,907,117
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-18,503,488
Tax Provision-2,226,835
Net Income From Continuing Ops-20,730,324-20,730,324
Net Income-20,707,555
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-851,329
 

Technical Analysis of Kyung Dong Pharmaceutical Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kyung Dong Pharmaceutical Co. Ltd. The general trend of Kyung Dong Pharmaceutical Co. Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kyung Dong Pharmaceutical Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kyung Dong Pharmaceutical Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 6,130 < 6,210 < 6,430.

The bearish price targets are: 5,825.

Tweet this
Kyung Dong Pharmaceutical Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kyung Dong Pharmaceutical Co. Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kyung Dong Pharmaceutical Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kyung Dong Pharmaceutical Co. Ltd. The current macd is -72.97368076.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kyung Dong Pharmaceutical Co. Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Kyung Dong Pharmaceutical Co. Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Kyung Dong Pharmaceutical Co. Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Kyung Dong Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartKyung Dong Pharmaceutical Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kyung Dong Pharmaceutical Co. Ltd. The current adx is 27.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Kyung Dong Pharmaceutical Co. Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Kyung Dong Pharmaceutical Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kyung Dong Pharmaceutical Co. Ltd. The current sar is 5,900.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Kyung Dong Pharmaceutical Co. Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kyung Dong Pharmaceutical Co. Ltd. The current rsi is 41.04. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Kyung Dong Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) ChartKyung Dong Pharmaceutical Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kyung Dong Pharmaceutical Co. Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kyung Dong Pharmaceutical Co. Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Kyung Dong Pharmaceutical Co. Ltd Daily Stochastic Oscillator ChartKyung Dong Pharmaceutical Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kyung Dong Pharmaceutical Co. Ltd. The current cci is -46.96705668.

Kyung Dong Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) ChartKyung Dong Pharmaceutical Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kyung Dong Pharmaceutical Co. Ltd. The current cmo is -17.75675636.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Kyung Dong Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartKyung Dong Pharmaceutical Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kyung Dong Pharmaceutical Co. Ltd. The current willr is -64.70588235.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Kyung Dong Pharmaceutical Co. Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Kyung Dong Pharmaceutical Co. Ltd Daily Williams %R ChartKyung Dong Pharmaceutical Co. Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kyung Dong Pharmaceutical Co. Ltd.

Kyung Dong Pharmaceutical Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kyung Dong Pharmaceutical Co. Ltd. The current atr is 131.33.

Kyung Dong Pharmaceutical Co. Ltd Daily Average True Range (ATR) ChartKyung Dong Pharmaceutical Co. Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kyung Dong Pharmaceutical Co. Ltd. The current obv is 28,414,831.

Kyung Dong Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) ChartKyung Dong Pharmaceutical Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kyung Dong Pharmaceutical Co. Ltd. The current mfi is 28.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Kyung Dong Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) ChartKyung Dong Pharmaceutical Co. Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kyung Dong Pharmaceutical Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Kyung Dong Pharmaceutical Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kyung Dong Pharmaceutical Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.040
Ma 20Greater thanMa 506,188.000
Ma 50Greater thanMa 1006,244.000
Ma 100Greater thanMa 2006,480.100
OpenGreater thanClose6,140.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Kyung Dong Pharmaceutical Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Kyung Dong Pharmaceutical Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kyung Dong Pharmaceutical Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kyung Dong Pharmaceutical Co. Ltd

I send you an email if I find something interesting about Kyung Dong Pharmaceutical Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Kyung Dong Pharmaceutical Co. Ltd.

Receive notifications about Kyung Dong Pharmaceutical Co. Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.